ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,440, issued on Sept. 29, was assigned to ProQR Therapeutics II B.V. (Leiden, Netherlands).
"Antisense oligonucleotides for the treatment of stargardt disease" was invented by Aliye Seda Yilmaz-Elis (Leiden, Netherlands), Peter Adamson (Leiden, Netherlands), Kalyana Chakravarthi Dulla (Leiden, Netherlands) and Iris Antoinette Ernestine Schulkens (Leiden, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the fields of medicine and biotechnology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Stargardt disease and/or ABCA4-associated e...